Revlimid (Lenalidomide) Now FDA Approved as First-Line Therapy for Patients with Multiple Myeloma.
Lisa A
LA
Raedler
Oncologist. 2013;18(1):27-36
23299777
BMJ Open. 2015 Nov 27;5(11):e009576
26614625
Oncologist. 2013;18(1):37-45
23299776
Blood. 2008 Mar 1;111(5):2516-20
17975015
Br J Biomed Sci. 2013;70(3):110-20
24273897
N Engl J Med. 2014 Sep 4;371(10):906-17
25184863
N Engl J Med. 2007 Nov 22;357(21):2123-32
18032762
N Engl J Med. 2007 Nov 22;357(21):2133-42
18032763